Nanosonics Inks Premier Deal to Expand Disinfection Tech Reach

INDIANAPOLIS, IN – March 02, 2026 – Nanosonics, Inc., a leader in infection prevention technology, has secured a significant national group purchasing agreement with Premier, Inc., one of the largest healthcare improvement companies in the United States. The deal, effective March 1, 2026, provides thousands of healthcare facilities in Premier’s network with pre-negotiated special pricing for Nanosonics' trophon®3 device, an automated system for high-level disinfection of ultrasound probes.

This partnership marks a pivotal moment for both patient safety and healthcare supply chain efficiency. By leveraging Premier's extensive reach, Nanosonics aims to accelerate the adoption of what is fast becoming a global standard in infection control. The agreement streamlines the procurement process for hospitals, making advanced disinfection technology more accessible and affordable.

"The launch of Nanosonics' Premier agreement provides these clinicians with the confidence to care, meeting patient safety and compliance standards for ultrasound high-level disinfection," said Bill Haydon, Nanosonics President of North America, in a statement. "As the industry leader in ultrasound high-level disinfection, this contract streamlines access to our proven, evidence-backed trophon technology to thousands of healthcare facilities and systems."

The Power of Group Purchasing

The agreement's significance is magnified by the immense scale of Premier, Inc. As a leading Group Purchasing Organization (GPO), Premier unites over 4,350 U.S. hospitals and approximately 300,000 other healthcare providers. This collective wields enormous purchasing power, with an estimated group purchasing volume exceeding $84 billion annually. GPOs are a cornerstone of the modern healthcare supply chain, utilized by an estimated 97% of U.S. hospitals to manage procurement.

By aggregating the purchasing volume of their members, GPOs like Premier negotiate favorable pricing and terms that individual facilities could not achieve alone. This typically translates into cost savings of 10-18% on contracted supplies and equipment. For Nanosonics, this agreement provides a highly efficient sales channel, granting direct access to a vast and motivated customer base. For Premier's member hospitals, it removes administrative hurdles and lowers the financial barrier to acquiring state-of-the-art medical technology.

These contracts do more than just lower prices; they standardize and simplify procurement, reduce administrative overhead, and ensure that products have been vetted for quality and reliability. In essence, the Nanosonics-Premier agreement creates a superhighway for the trophon3 device to reach a substantial portion of the American healthcare landscape.

A Strategic Move in a Competitive Market

Nanosonics' deal with Premier is a calculated move in the rapidly growing and increasingly competitive ultrasound probe disinfection market. With an existing global install base of over 35,000 devices and revenues of $170 million in fiscal 2024, the Australian company is already a dominant force. However, the market is projected to expand significantly, with some estimates suggesting it will grow from approximately $855 million in 2025 to over $2.1 billion by 2032.

This growth has attracted a range of competitors. Companies like CIVCO Medical Solutions with its ASTRA reprocessors, CS Medical with its TD 100 disinfector, and the French firm Germitec with its chemical-free UV-C technology are all vying for market share. These competitors differentiate on factors like cycle time, disinfectant type, and device footprint. The Premier agreement provides Nanosonics with a powerful competitive advantage, effectively endorsing its technology and embedding it within the procurement ecosystem of a massive healthcare network.

By securing this contract, Nanosonics not only expands its market reach but also reinforces its position as the industry leader. It makes the trophon3 system the path of least resistance for thousands of providers, potentially solidifying its market share for years to come.

Elevating the Standard of Patient Care

Beyond the business implications, the agreement has profound potential to improve patient safety. Ultrasound probes, particularly semi-critical probes used in transvaginal, transrectal, and transesophageal procedures, pose a significant risk of cross-contamination if not properly disinfected. Inadequate cleaning can lead to the transmission of dangerous pathogens and contribute to healthcare-associated infections (HAIs).

Studies have shown that even with the use of probe covers, pathogens like the Human Papillomavirus (HPV) can persist on transducers if only low-level disinfection is performed. The Centers for Disease Control and Prevention (CDC) and other regulatory bodies mandate high-level disinfection (HLD) for all semi-critical devices to mitigate this risk.

The trophon3 device automates this critical process. It uses a sonically activated hydrogen peroxide mist to perform HLD in a rapid four-minute cycle. This automated, enclosed system minimizes the potential for human error inherent in manual soaking methods and reduces staff exposure to harsh chemicals. By making this technology more accessible, the Premier agreement facilitates a higher, more consistent standard of infection control.

Modernizing Hospital Workflows and Compliance

For hospitals and clinics, the adoption of technology like the trophon3 represents a significant modernization of internal workflows. The latest trophon3 device integrates features designed for the data-driven reality of modern healthcare, including built-in traceability and connectivity options. Its AuditPro Compliance Management System can integrate with hospital information systems (RIS and PACS) and supports DICOM, creating an automated digital record of each disinfection cycle.

This automated documentation is invaluable for audit readiness and demonstrating compliance with increasingly strict regulatory standards. It replaces cumbersome manual logs, reduces administrative burdens, and provides a robust, verifiable record of infection control practices. The standardization offered by an automated system ensures that every probe receives the same validated level of disinfection, every time, improving reliability and workflow efficiency in busy ultrasound departments.

While the initial investment in automated systems can be a consideration for healthcare facilities, the GPO agreement helps mitigate this cost. Furthermore, the long-term economic benefits are compelling, stemming from reduced labor costs, prevention of costly HAIs, and the protection of expensive ultrasound probes from damage associated with improper manual handling. This partnership between Nanosonics and Premier is more than a simple supply contract; it is a catalyst for widespread adoption of a technology that promises to make healthcare safer, more efficient, and more compliant.